Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon L Croft

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
The Indian Journal of Medical Research|September 30, 2008
PKDL--a drug related phenomenon?Simon L Croft
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 10, 2005
Public-private partnership: from there to hereSimon L Croft
Current Opinion in Investigational Drugs (London, England : 2000)|March 3, 2007
Neglected diseases: progress in drug developmentSimon L Croft
Parasitology|October 7, 2017
Leishmania and other intracellular pathogens: selectivity, drug distribution and PK-PDSimon L Croft
Genome Biology|March 16, 2016
Neglected tropical diseases in the genomics era: re-evaluating the impact of new drugs and mass drug administrationSimon L Croft
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Topical treatment for cutaneous leishmaniasisTracy Garnier, Simon L Croft
Science Translational Medicine|December 4, 2015
The Nobel Prize in Medicine 2015: Two drugs that changed global healthSimon L Croft, Steven Ward
Current Pharmaceutical Design|February 28, 2002
Chemotherapy of leishmaniasisSimon L Croft, Vanessa Yardley
Antimicrobial Agents and Chemotherapy|December 27, 2005
In vitro and in vivo interactions between miltefosine and other antileishmanial drugsKarin Seifert, Simon L Croft
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 15, 2006
Miltefosine--discovery of the antileishmanial activity of phospholipid derivativesSimon L Croft, Juergen Engel
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
The Indian Journal of Medical Research|September 30, 2008
PKDL--a drug related phenomenon?Simon L Croft
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 10, 2005
Public-private partnership: from there to hereSimon L Croft
Current Opinion in Investigational Drugs (London, England : 2000)|March 3, 2007
Neglected diseases: progress in drug developmentSimon L Croft
Parasitology|October 7, 2017
Leishmania and other intracellular pathogens: selectivity, drug distribution and PK-PDSimon L Croft
Genome Biology|March 16, 2016
Neglected tropical diseases in the genomics era: re-evaluating the impact of new drugs and mass drug administrationSimon L Croft
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Topical treatment for cutaneous leishmaniasisTracy Garnier, Simon L Croft
Science Translational Medicine|December 4, 2015
The Nobel Prize in Medicine 2015: Two drugs that changed global healthSimon L Croft, Steven Ward
Current Pharmaceutical Design|February 28, 2002
Chemotherapy of leishmaniasisSimon L Croft, Vanessa Yardley
Antimicrobial Agents and Chemotherapy|December 27, 2005
In vitro and in vivo interactions between miltefosine and other antileishmanial drugsKarin Seifert, Simon L Croft
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 15, 2006
Miltefosine--discovery of the antileishmanial activity of phospholipid derivativesSimon L Croft, Juergen Engel
Pageof 15